Prioritise gastric bypass as the most clinically and cost effective weight loss surgery
Over 3 million adults in the UK are living with severe obesity (BMI ≥40, or ≥35 with comorbidities), which raises the risk of diabetes, heart disease, cancer, poor mental health, time off work, and early death. These individuals need effective, evidence-based support. New weight loss medicines show promise, but important questions remain about long term results and value for money. For those with severe obesity, surgery is a proven and effective intervention. Until recently, it was unclear which operation offered the best outcomes for patients and the NHS, and there was no national policy on which procedure to prioritise. The landmark By-Band-Sleeve trial compared three surgical procedures—gastric bypass, sleeve gastrectomy, and adjustable gastric banding. The results are unequivocal: at three years, the Roux en Y version of gastric bypass delivered the best weight loss, the greatest health gains, and the best value for money. Smaller European studies report similar patterns, supporting these findings.

































































